Skip to main content
Toggle navigation
Login
Search
Home
Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Fudan Zheng, PhD
Principal Scientist Pharmacometrics
Johnson & Johnson Innovative Medicine
Poster(s):
(T-139) Population Pharmacokinetics and Exposure-response Analyses of Amivantamab Administered in Combination with Lazertinib as First-Line Treatment in Patients With EGFR-Mutated Non-Small Cell Lung Cancer
Tuesday, November 12, 2024
7:00 AM – 5:00 PM
MST
